44 results
8-K
EX-99.1
ubogalwdk2
6 Dec 22
Regulation FD Disclosure
8:01am
DEF 14A
lt5w g124cahv
2 Sep 22
Definitive proxy
8:30am
S-3
EX-4.8
wridp9tp6d8zwuk
5 Aug 22
Shelf registration
5:08pm
S-3
8dne77i2
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.9
cpv3jye20dzw
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
i3l0g 7qxly0
6 Jun 22
Regulation FD Disclosure
8:37am
8-K
EX-99.1
5d195jm12e2y
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm